Research compensation and the monetarization of medicine

JAMA

Volumn 293, Issue 5, 2005, Pages 613-614

  Reiser, Stanley Joel ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRUISM; COMMERCIAL PHENOMENA; COMPENSATION; COST BENEFIT ANALYSIS; MEDICAL CARE; MEDICINE; MONEY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; SHORT SURVEY;

EID: 12844268659     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.5.613     Document Type: Short Survey

References (7)

1. Dunn LB, Gordon NE. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA. 2005;293:609-612.
2. Cunny KA, Miller HW. Participation in clinical drug studies: motivations and barriers. Clin Ther. 1994;16:273-282.
3. The Nuremberg Code: Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10. Vol 2. Washington, DC: US Government Printing Office; 1949:181-182.
4. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office; 1979.
5. Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136:368-373.
6. Precepts. In: Jones WHS, trans. Hippocrates. Vol I. Cambridge, Mass: Harvard University Press; 1923:319.
7. Heffler S, Smith S, Keehan S, et al. Health spending projections through 2013. Health Aff (Millwood) [serial online]. February 11, 2004; 79-93. Available at: http://content.healthaffairs.org/cgi/reprinthlthaff. Accessed January 4, 2005.